These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36977449)

  • 1. Editorial commentary: Heart rate and rhythm in cardiac amyloidosis.
    Sperry BW; Sandesara UB; Kline JA
    Trends Cardiovasc Med; 2024 May; 34(4):254-256. PubMed ID: 36977449
    [No Abstract]   [Full Text] [Related]  

  • 2. A review of transthyretin cardiac amyloidosis.
    Jhawar N; Moreno JCL; Chirila R
    Rom J Intern Med; 2023 Mar; 61(1):28-34. PubMed ID: 36278951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrocardiographic features and rhythm disorders in cardiac amyloidosis.
    Martini N; Sinigiani G; De Michieli L; Mussinelli R; Perazzolo Marra M; Iliceto S; Zorzi A; Perlini S; Corrado D; Cipriani A
    Trends Cardiovasc Med; 2024 May; 34(4):257-264. PubMed ID: 36841466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent atrial standstill in non-compaction cardiomyopathy.
    Ying ZQ; Ma J; Xu G
    Eur J Intern Med; 2008 Dec; 19(8):637. PubMed ID: 19046733
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathophysiology and treatment of cardiac amyloidosis.
    Gertz MA; Dispenzieri A; Sher T
    Nat Rev Cardiol; 2015 Feb; 12(2):91-102. PubMed ID: 25311231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Systemic embolism and thrombosis of the left atrium in a patient in sinus rhythm with cardiac amyloidosis].
    Roudaut R; Pepin C; Marazanof M; Bonnet J
    Ann Cardiol Angeiol (Paris); 1996 Mar; 45(3):119-21. PubMed ID: 8762913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial commentary: Is seeing really believing? The role of the 12 lead electrocardiogram in cardiac amyloidosis.
    Devgun J; Ananthasubramaniam K
    Trends Cardiovasc Med; 2024 May; 34(4):265-266. PubMed ID: 36918135
    [No Abstract]   [Full Text] [Related]  

  • 8. Indexed left ventricular mass to QRS voltage ratio is associated with heart failure hospitalizations in patients with cardiac amyloidosis.
    Slivnick JA; Wallner AL; Vallakati A; Truong VT; Mazur W; Elamin MB; Tong MS; Raman SV; Zareba KM
    Int J Cardiovasc Imaging; 2021 Mar; 37(3):1043-1051. PubMed ID: 33068247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes following cardioversion for patients with cardiac amyloidosis and atrial fibrillation or atrial flutter.
    Loungani RS; Rehorn MR; Geurink KR; Coniglio AC; Black-Maier E; Pokorney SD; Khouri MG
    Am Heart J; 2020 Apr; 222():26-29. PubMed ID: 32004797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Screening for Transthyretin Amyloid Cardiomyopathy in Patients With Atrial Fibrillation.
    Prasad P; Howell S; Sanghai S; Stecker E; Henrikson CA; Masri A; Nazer B
    Circulation; 2022 Nov; 146(22):1730-1732. PubMed ID: 36441818
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
    Rubin J; Maurer MS
    Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac amyloidosis.
    Yusuf SW; Solhpour A; Banchs J; Lopez-Mattei JC; Durand JB; Iliescu C; Hassan SA; Qazilbash MH
    Expert Rev Cardiovasc Ther; 2014 Feb; 12(2):265-77. PubMed ID: 24386926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conduction system disease in cardiac amyloidosis.
    Assaf A; Mekhael M; Noujaim C; Chouman N; Younes H; Kreidieh O; Marrouche N; Donnellan E
    Trends Cardiovasc Med; 2024 May; 34(4):250-253. PubMed ID: 36804858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac amyloidosis, contrictive pericarditis and restrictive cardiomyopathy.
    Meaney E; Shabetai R; Bhargava V; Shearer M; Weidner C; Mangiardi LM; Smalling R; Peterson K
    Am J Cardiol; 1976 Nov; 38(5):547-56. PubMed ID: 983951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 86-year-old man with atrial fibrillation and dyspnea on exertion.
    Chandra SM; Chon TY
    Mayo Clin Proc; 2014 Feb; 89(2):254-8. PubMed ID: 24485136
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of prognostic markers in transthyretin and AL cardiac amyloidosis.
    Damy T; Jaccard A; Guellich A; Lavergne D; Galat A; Deux JF; Hittinger L; Dupuis J; Frenkel V; Rigaud C; Plante-Bordeneuve V; Bodez D; Mohty D
    Amyloid; 2016 Sep; 23(3):194-202. PubMed ID: 27647161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Misconceptions and Facts About Cardiac Amyloidosis.
    Nguyen FD; Rodriguez M; Krittanawong C; Witteles R; Lenihan DJ
    Am J Cardiol; 2021 Dec; 160():99-105. PubMed ID: 34610875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac amyloidosis: from clinical suspicion to morphological diagnosis.
    Flodrova P; Flodr P; Pika T; Vymetal J; Holub D; Dzubak P; Hajduch M; Scudla V
    Pathology; 2018 Apr; 50(3):261-268. PubMed ID: 29448998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death. A scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention.
    Goldberger JJ; Cain ME; Hohnloser SH; Kadish AH; Knight BP; Lauer MS; Maron BJ; Page RL; Passman RS; Siscovick D; Stevenson WG; Zipes DP; ; ;
    J Am Coll Cardiol; 2008 Sep; 52(14):1179-99. PubMed ID: 18804749
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiac amyloidosis: combined use of two-dimensional echocardiography and electrocardiography in noninvasive screening before biopsy.
    Sivaram CA; Jugdutt BI; Amy RW; Basualdo CA; Haraphongse M; Shnitka TK
    Clin Cardiol; 1985 Oct; 8(10):511-8. PubMed ID: 4053429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.